Viewing Study NCT00271466

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-02-11 @ 12:46 PM
Study NCT ID: NCT00271466
Status: COMPLETED
Last Update Posted: 2011-05-18
First Post: 2005-12-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None opioid View
None fentanyl View
None Duragesic View
None transdermal View
None chronic pain View
None morphine View